-
1
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Published 2018-10-01Subjects: “…Rapidly progressive interstitial lung disease…”
Get full text
Article -
2
Clinical features of macrophage activation syndrome in adult dermatomyositis: A single‐center retrospective case‐control study
Published 2024-01-01Subjects: Get full text
Article -
3
-
4
-
5
Erythematous auricular papules in the fatal cases of anti-MDA5 antibody-positive interstitial lung disease
Published 2020-01-01Subjects: Get full text
Article -
6
Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
Published 2024-10-01Subjects: Get full text
Article -
7
Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients
Published 2024-01-01Subjects: Get full text
Article -
8
-
9
Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
Published 2018-05-01Subjects: Get full text
Article -
10
-
11
Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
Published 2023-07-01Subjects: Get full text
Article -
12
-
13
-
14
-
15
Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
Published 2024-02-01Subjects: Get full text
Article -
16
-
17
-
18
Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
Published 2020-01-01Subjects: “…Rapidly progressive interstitial lung disease…”
Get full text
Article -
19
-
20